The pale hand of a woman with severe anemia (right) in comparison to the normal hand of her husband (left) List of hematologic conditions From Wikipedia, the free encyclopedia This is an incomplete list, which may never be able to satisfy certain standards for completion. There are many conditions of or affecting the human Hematologic system — the Biological system that includes plasma, platelets, leukocytes, and erythrocytes, the major components of blood and the bone marrow. [1] Contents 1 Anemias 1.1 Nutritional anemias 1.2 Haemolytic, Aplastic and other anemias 2 Blood cancers 2.1 Lymphoma 2.2 Leukemia 2.3 Myeloma 2.4 Malignant immunoproliferative diseases 3 Coagulation, purpura, and other hemorrhagic conditions 4 Infection-related 4.1 Bacterium-related 4.2 Protozoan-related 5 Immune system regulation-related 5.1 Immunodeficiency with predominantly antibody defects 6 References Anemias Main article: Anemia An anemia is a decrease in number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood. [2][3] However; it can include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in some other types of hemoglobin deficiency. Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemia can be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, to mention a few. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low- volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Based on 2005- 2006 estimates, the Centers for Disease Control and Prevention, has stated that approximately 5.5 million Americans a year are either admitted to a hospital or seen by a physician, with some form of anemia as their primary diagnosis. [4] Nutritional anemias A nutritional anemia refers to a type of anemia that can be directly attributed to either a nutritional disorder or a nutritional deficiency. Condition name ICD-10 coding number Diseases Database coding number Medical Subject Headings Iron deficiency anemia D50. (http://apps.who.int/classifications/apps/icd/icd10online/? gd50.htm+d50) 6947 (http://www.diseasesdatabase.com/ddb6947.htm) Iron deficiency anemia (or iron deficiency anaemia) is a common anemia that occurs when iron loss (often from intestinal bleeding or menses) occurs, and/or the dietary intake or absorption of iron is insufficient. In such a state, hemoglobin, which contains iron, cannot be formed. [5] Plummer-Vinson syndrome D50.1 (http://apps.who.int/classifications/apps/icd/icd10online/? gd50.htm+d501) 10134 (http://www.diseasesdatabase.com/ddb10134.htm) Plummer-Vinson syndrome (PVS), also called Paterson-Brown-Kelly syndrome or sideropenic dysphagia presents as a triad of dysphagia (due to esophageal webs), glossitis, and iron deficiency anemia. [6] It most usually occurs in postmenopausal women. Vitamin B12 deficiency anemia E53.8 (http://apps.who.int/classifications/apps/icd/icd10online/? ge50.htm+e538) 13905 (http://www.diseasesdatabase.com/ddb13905.htm) Vitamin B12 deficiency anemia occurs when a "lower-than-normal" amount of the vitamin B12 is available within the body, leading to a decreased production of healthy red blood cells. [7]
Transcript
The pale hand of a woman withsevere anemia (right) incomparison to the normal hand ofher husband (left)
List of hematologic conditionsFrom Wikipedia, the free encyclopedia
This is an incomplete list, which may never be able to satisfy certain standards for completion.
There are many conditions of or affecting the human Hematologic system — the Biological system that includes plasma, platelets, leukocytes, and erythrocytes, the majorcomponents of blood and the bone marrow.[1]
Contents
1 Anemias1.1 Nutritional anemias1.2 Haemolytic, Aplastic and other anemias
3 Coagulation, purpura, and other hemorrhagic conditions4 Infection-related
4.1 Bacterium-related4.2 Protozoan-related
5 Immune system regulation-related5.1 Immunodeficiency with predominantly antibody defects
6 References
Anemias
Main article: Anemia
An anemia is a decrease in number of red blood cells (RBCs) or less than the normal quantity of hemoglobin in the blood.[2][3] However; itcan include decreased oxygen-binding ability of each hemoglobin molecule due to deformity or lack in numerical development as in someother types of hemoglobin deficiency.
Anemia is the most common disorder of the blood. There are several kinds of anemia, produced by a variety of underlying causes. Anemiacan be classified in a variety of ways, based on the morphology of RBCs, underlying etiologic mechanisms, and discernible clinical spectra, tomention a few. The three main classes of anemia include excessive blood loss (acutely such as a hemorrhage or chronically through low-volume loss), excessive blood cell destruction (hemolysis) or deficient red blood cell production (ineffective hematopoiesis). Based on 2005-2006 estimates, the Centers for Disease Control and Prevention, has stated that approximately 5.5 million Americans a year are eitheradmitted to a hospital or seen by a physician, with some form of anemia as their primary diagnosis.[4]
Nutritional anemias
A nutritional anemia refers to a type of anemia that can be directly attributed to either a nutritional disorder or a nutritional deficiency.
Condition name ICD-10 coding number Diseases Database coding numberMedicalSubject
Headings
Iron deficiency anemiaD50.(http://apps.who.int/classifications/apps/icd/icd10online/?gd50.htm+d50)
6947(http://www.diseasesdatabase.com/ddb6947.htm)
Iron deficiency anemia (or iron deficiency anaemia) is a common anemia that occurs when iron loss (often from intestinal bleeding or menses) occurs, and/or the dietary intake orabsorption of iron is insufficient. In such a state, hemoglobin, which contains iron, cannot be formed.[5]
Plummer-Vinson syndrome (PVS), also called Paterson-Brown-Kelly syndrome or sideropenic dysphagia presents as a triad of dysphagia (due to esophageal webs), glossitis, andiron deficiency anemia.[6] It most usually occurs in postmenopausal women.
Vitamin B12 deficiency anemia occurs when a "lower-than-normal" amount of the vitamin B12 is available within the body, leading to a decreased production of healthy red bloodcells.[7]
Vitamin B12 deficiency anemia due to intrinsic factordeficiency
Pernicious anemia (also known as Macrocytic achylic anemia, Congenital pernicious anemia, Juvenile pernicious anemia, and Vitamin B12 deficiency) is one of many types of thelarger family of megaloblastic anemias. It is caused by loss of gastric parietal cells, and subsequent inability to absorb vitamin B12. Pernicious anemia is the result of inadequate
production of the protein intrinsic factor needed by the body to absorb vitamin B 12, causing a reduction of new red blood cells.[8]
Vitamin B 12 deficiency anemia due to selectivevitamin B 12 malabsorption with proteinuria
Vitamin B 12 deficiency anemia due to selective vitamin B 12 malabsorption with proteinuria (also known as Imerslund-Gräsbeck syndrome) is a rare autosomal recessivedisorder which requires the indefinite administration of Vitamin B12 injections.[9]
Megaloblastic anemia (or megaloblastic anaemia) is an anemia (of macrocytic classification) that results from inhibition of DNA synthesis in red blood cell production.[10]
Transcobalamin II deficiencyD51.2(http://apps.who.int/classifications/apps/icd/icd10online/?gd50.htm+d512)
Transcobalamin II deficiency (TCII) (also known as hereditary transcobalamin II deficiency) is a rare autosomal recessive disorder that results in neurological dysfunction.[11]
Transcobalamin II are a type of carrier proteins which bind with plasma vitamin B12 (cobalamin) in the production of red blood cells.[12]
Folate-deficiency anemia (also known as dietary folate-deficiency anemia) is a condition that develops when the body does not have the adequate supply of folic acid available thatis needed for the production of new healthy blood cells.[13]
Nutritional Megaloblastic anemia is an anemia (of macrocytic classification) that results from inhibition of DNA synthesis in red blood cell production.[10]
Scurvy is a disease resulting from a deficiency of vitamin C,[15] which is required for the synthesis of collagen in humans.
Haemolytic, Aplastic and other anemias
Condition name ICD-10 coding number Diseases Database coding numberMedicalSubject
Headings
Acanthocytosis
Acanthocytosis (also known as Abetalipoproteinemia, Apolipoprotein B deficiency, and Bassen-Kornzweig syndrome) is a rare, genetically inherited, autosomal recessive
condition that causes the inability to fully digest dietary fats in the intestines. The gene responsible for this condition is the microsomal triglyceride transfer protein gene.[16]
Acute posthemorrhagic anemia (also known as acute blood loss anemia) is a condition in which a person quickly loses a large volume of circulating hemoglobin. Acute blood lossis usually associated with an incident of trauma or a severe injury resulting in a large loss of blood. It can also occur during or after a surgical procedure.[17]
Alpha-thalassemia (α-thalassemia) is a form of thalassemia involving the genes HBA1 [18] and HBA2.[19] It is condition that causes a reduction of hemoglobin production. Thereare two types of Alpha-thalassemia named hemoglobin Bart hydrops fetalis syndrome (also known as Hb Bart syndrome) and HbH disease.[20]
Anemia is a general medical term used to describe a number of conditions that result in a decrease in the number of red blood cells (RBCs) or less than the normal quantity ofhemoglobin in the blood.[2]
Anemia of chronic disease
Anemia of chronic disease (ACD) (also known as anemia of inflammatory response) is a condition where the body converts iron into unused ferrin, causing a drop in hemoglobinproduction, and as a result; decreased red blood cell production and count. This is caused by a natural defense mechanism initiated by an inflammatory response in response to theunderlying chronic disease.[21]
Anemia in Kidney Disease and Dialysis
Anemia in Kidney Disease and Dialysis results from the diseased kidney's inability to produce enough of the hormone erythropoietin. Erythropoietin is used to stimulate anadequate production of red blood cells from the bone marrow.[22]
Anemia of prematurityP61.2(http://apps.who.int/classifications/apps/icd/icd10online/?gp50.htm+p612)
Anemia of prematurity refers to a form of anemia affecting preterm infants[23] with decreased hematocrit.[24]
Autoimmune hemolytic anemia (AIHA) is a type of hemolytic anemia where the body's immune system attacks its own red blood cells (RBCs), leading to their destruction(hemolysis).[26][27] Types of AIHA include Warm autoimmune hemolytic anemia, Cold agglutinin disease, and Paroxysmal cold hemoglobinuria.
Beta-thalassemia (β-thalassemia) is an autosomal dominant blood condition that results in the reduction of hemoglobin production. The cause for the disorder is related to a geneticmutation of the HBB gene. This gene is responsible for providing the instructions to produce beta-globin; one of the major components of hemoglobin. The two classification typesof beta thalassemia are thalassemia major (also known as Cooley's anemia) and thalassemia intermedia.[28]
Diamond–Blackfan anemia (DBA), (also known as Blackfan–Diamond anemia and Inherited erythroblastopenia) [29] is a congenital erythroid aplasia that usually presents ininfancy.[30]
Congenital dyserythropoietic anemia (CDA) is a generically inherited autosomal recessive (types I and II) or autosomal dominant (type III) blood disorder that effects the normalmaturation process of red blood cell production. Mutations to the CDAN1 gene (type I), SEC23B gene (type II), and a currently unknown gene for type III causes a disruption inthe normal formation of erythropoiesis, thereby causing a reduction of circulating healthy mature red blood cells.[31]
Drug-induced autoimmune hemolytic anemia is a type of hemolytic anemia in which a mediated immune response triggers IgG and IgM antibody production in regards to thepresence of high doses of penicillin via the hapten mechanism causing the reduction of red blood cells in the spleen.[32]
Hemoglobinopathy is a kind of genetic defect that results in abnormal structure of one of the globin chains of the hemoglobin molecule.[33] Hemoglobinopathies are inherited single-gene disorders; in most cases, they are inherited as autosomal co-dominant traits.[34] Hemoglobinopathies imply structural abnormalities in the globin proteins themselves.[35]
Hemoglobinopathy variants include sickle-cell disease.[36]
Hemolytic anemia (also known as haemolytic anaemia) is an anemia due to hemolysis, the abnormal breakdown of red blood cells. A number of different mediating factors cancause this condition; either from within the blood cell itself ((intrinsic factors) or outside of the cell (extrinsic factors).[37]
Hereditary spherocytosis is a genetically-transmitted (autosomal dominant) form of spherocytosis, an auto-hemolytic anemia characterized by the production of red blood cells thatare sphere-shaped rather than bi-concave disk shaped (Donut-Shaped), and therefore more prone to hemolysis.[39]
Hereditary elliptocytosis (HE) (also known as ovalocytosis), is an inherited blood disorder in which an abnormally large number of circulating red blood cells are elliptical or cigarshaped rather than the typical biconcave disc shape. It is caused in part by mutations in the formation of specific Spectrin tetramers or proteins responsible for giving the red bloodcell its shape and elasticity causing continued deformation as the cell matures.[40] Subtypes of this condition include southeast Asian ovalocytosis and spherocytic elliptocytosis.
Hereditary pyropoikilocytosis
Hereditary pyropoikilocytosis (HPP) is an autosomal recessive form of hemolytic anemia which typically presents at infancy or early childhood, characterized by abnormal redblood cell morphology including "budding red cells, fragmented red cells, spherocytes, elliptocytes, triangular cells, and other bizarre-shaped red cells." [41]
Cold hemagglutinin disease (also known as cold agglutinin disease and autoimmune anemia due to cold-reactive antibodies)is an autoimmune disease characterized by the presenceof high concentrations of circulating antibodies, usually IgM, directed against red blood cells.[42] It is a form of autoimmune hemolytic anemia, specifically one in which antibodiesonly bind red blood cells at low body temperatures, typically 28-31°C.
Paroxysmal cold hemoglobinuria (PCH) (also known as Donath-Landsteiner syndrome) is a rare condition characterized by the sudden presence of hemoglobin in the urine (called[43]
hemoglobinuria), typically after exposure to cold temperatures.[43]
Hemolytic-uremic syndrome (HUS) (also known as haemolytic-uraemic syndrome) is a disease characterized by hemolytic anemia, acute renal failure (uremia) and a low plateletcount (thrombocytopenia). It predominantly but not exclusively affects children. Most cases are preceded by an episode of diarrhea caused by E. coli O157:H7, which is acquiredas a foodborne illness.[44]
Hereditary stomatocytosis describes a number of inherited autosomal dominant human conditions which affect the red blood cell, in which the membrane or outer coating of the cell'leaks' sodium and potassium ions, causing cell lyses and eventual haemolytic anaemia.
Hexokinase deficiency (also known as human erythrocyte hexokinase deficiency) is an anemia-causing condition associated with inadequate hexokinase.[45]
Hyperanaemia
Hypochromic anemia
Hypochromic anemia is a generic term for any type of anemia in which the red blood cells (erythrocytes) are paler than normal.[46] This is caused by a proportionally reducedamount of hemoglobin present in relation to the size of the red blood cell.
Ineffective erythropoiesis
Ineffective erythropoiesis is an anemia caused by the premature apoptosis of the body's mature red blood cells [47] and subsequent reduction in an adequate production and fullmaturation of new healthy red blood cells.[48]
Megaloblastic anemia (or megaloblastic anaemia) is an anemia of macrocytic classification that results from inhibition of DNA synthesis in red blood cell production.[10]
Myelophthisic anemia (also known as myelophthisis) is a severe kind of anemia found in some people with diseases that affect the bone marrow. Myelophythisis refers to thedisplacement of hemopoietic bone-marrow tissue into the peripheral blood,[49] either by fibrosis, tumors or granulomas.
Neuroacanthocytosis (also known as Levine-Critchley syndrome) are a group of rare, genetic conditions that are characterized by movement disorders and acanthocytosis.[50]
Chorea-acanthocytosis (ChAc)(also known as Levine-Critchley syndrome, acanthocytosis with neurologic disorder, neuroacanthocytosis, and choreoacanthocytosis)[51] is a rarehereditary disease caused by a mutation of the gene that directs structural proteins in red blood cells. It belongs to a group of four diseases characterized asneuroacanthocytosis.[52]
Non sideropenic hypochromic anaemia
Normocytic anemia
A normocytic anemia is a general term for an anemia with an Mean corpuscular volume (MCV) of 80-100.
Paroxysmal nocturnal hemoglobinuriaD59.5(http://apps.who.int/classifications/apps/icd/icd10online/?d55 h d595)
9688
(htt // di d t b /ddb9688 ht )
Seven-year-old Nigerian boy withBurkitt's lymphoma presentingwith a severely ulcerated andswollen jaw.
Pyruvate kinase deficiency, also called erythrocyte pyruvate kinase deficiency,[53] is an inherited metabolic disorder of the enzyme pyruvate kinase which affects the survival of redblood cells and causes them to deform into echinocytes on peripheral blood smears.
Rh deficiency syndrome
Rh deficiency syndrome is a type of hemolytic anemia that involves erythrocytes whom membranes are deficient in Rh antigens. It is considered a rare condition.[54]
Sideroblastic anemia or sideroachrestic anemia is a disease in which the bone marrow produces ringed sideroblasts rather than healthy red blood cells (erythrocytes).[55] It may becaused either by a genetic disorder or indirectly as part of myelodysplastic syndrome.[56]
Southeast Asian ovalocytosisD58.1(http://apps.who.int/classifications/apps/icd/icd10online/?gd55.htm+d581)
9416(http://www.diseasesdatabase.com/ddb9416.htm)
Southeast Asian ovalocytosis (also known as Stomatocytic ovalocytosis, stomatocytic elliptocytosis, and Melanesian ovalocytosis) is a form of hereditary elliptocytosis common insome communities in Malaysia and Papua New Guinea, as it confers some resistance to cerebral Falciparum Malaria.[57]
Spur cell hemolytic anemia
Spur cell hemolytic anemia is a form of hemolytic anemia that results when free cholesterol binds to the red blood cell's membrane increasing its surface area, causing laterdeformities such as rough or thorny projections on the erythrocyte named acanthocytes. This condition is caused by the deceased liver's decreased ability to esterificatecholesterol.[58]
Triosephosphate isomerase (TPI) deficiency is a genetically inherited autosomal recessive condition "characterized bychronic hemolytic anemia, cardiomyopathy, susceptibility toinfections, severe neurological dysfunction, and, in most cases, death in early childhood." [59]
Warm autoimmune hemolytic anemia is an autoimmune hemolytic anemia (AIHA) characterized by formation of antibodies that attack the body's own red blood cells in adestructive immune system response.[60]
Blood cancers
A blood cancer or hematological malignancy is a type of malignant cancer that originates, affects, or involves the blood, bone marrow, orlymph nodes.[61] These cancers include leukemias, lymphomas, and myelomas. These particular types of cancers can arise as defectedmature cell types that have differentiated from hematopoietic precursor cells (often in the bone marrow) and begin to quickly proliferatethrough the bloodstream where it can then often infiltrate other organs and tissues. Others can involve the formation of tumors fromlymphoblasts from within the lymphoid tissue.[62] Incidences of affected people with a form of blood cancer has been steady increasing overrecent years; however, due in part to early detection methods and subsequent advancements in the treatment of the diseases, mortality rateshave continued to decrease.[63]
Angioimmunoblastic T-cell lymphoma (AILT) (also known as Angioimmunoblastic lymphadenopathy with dysproteinemia) [65]:747) is a mature T-cell lymphoma with systemiccharacterized by a polymorphous lymph node infiltrate showing a marked increase in follicular dendritic cells (FDCs) and high endothelial venules (HEVs) and systemicinvolvement.[66] It is also known as immunoblastic lymphadenopathy (Lukes-Collins Classification) and AILD-type (lymphogranulomatosis X) T-cell lymphoma (KielClassification) [66]
Hepatosplenic T-cell lymphoma
Hepatosplenic T-cell lymphoma is a systemic neoplasm comprising medium-sized cytotoxic T-cells that show a significant sinusoidal infiltration in the liver, spleen, and bonemarrow.[67] It is a rare and generally incurable form of lymphoma.[68]
Follicular Lymphoma also known as (indolent follicular lymphoma) is a type of non-hodgkin's lymphoma that involves both large and small B-cell lymphocytes that spreads fromthe lymphatic system and into the blood, bone marrow, and internal organs. Approximately 20 to 30 percent of non-hodgkin's lymphomas are diagnosed as follicular lymphoma,with a majority of cases involving those 60 years of age or older.[69]
Mucosa-Associated Lymphatic Tissue lymphoma 31339
Mucosa-Associated Lymphatic Tissue lymphoma (as known as MALT lymphoma and extra-nodal marginal zone lymphoma) is a condition in which lymphatic tissue abnormallypresents outside the lymphatic system (extra-nodular) and instead within the mucosa of the gastrointestinal tract, typically as a lesion in the stomach.[70]
B-cell chronic lymphocytic leukemia (also known as small cell lymphocytic lymphoma) is a blood cancer that involves the B-cell lymphocytes; responsible for the creation ofantibodies. Of the two general types of chronic lymphocytic leukemias (the other involving T-cells), B-cell chronic lymphocytic leukemia accounts for approximately 95 percent ofthe diagnoses.[71]
Mantle cell lymphoma (MCL) is a type of B-cell lymphoma an and one of the rarest forms of non-Hodgkin's lymphomas comprising approximately 6% of diagnosed cases.[72]
Burkitt lymphoma (also known as Burkitt's tumor, Burkitt lymphoma or malignant lymphoma, Burkitt's type) is a type of B-cell lymphoma that is categorized into one of varianttypes. These are variants are endemic (occurring in equatorial Africa), sporadic ("non-African"), and immunodeficiency-associated (usually associated with HIV).
Waldenström's macroglob line (also kno n as l mphoplasmac tic l mphoma) is a l mphoproliferati e disease that in ol es an abnormal increase of l mphoc tes ithin the bone
Waldenström's macroglobuline (also known as lymphoplasmacytic lymphoma) is a lymphoproliferative disease that involves an abnormal increase of lymphocytes within the bonemarrow, creasing disruption of normal red blood cell production.[73]
Nodal marginal zone B cell lymphoma
Splenic marginal zone lymphoma
Splenic marginal zone lymphoma (SMZL) (also known as well-differentiated lymphocytic lymphoma, small lymphocytic lymphoma, and splenic lymphoma with circulating villouslymphocytes) is a lymphoma made up of small B-cells that replace the normal architecture of the white pulp of the spleen. The neoplastic cells are both small lymphocytes andlarger, transformed blasts, and they invade the mantle zone of splenic follicles and erode the marginal zone, ultimately invading the red pulp of the spleen. Frequently, the bonemarrow and splenic hilar lymph nodes are involved along with the peripheral blood.[74]
Intravascular large B-cell lymphoma
Primary effusion lymphoma 33904
Primary effusion lymphoma is a condition caused by Kaposi's sarcoma-associated herpesvirus (KSHV) [75]
Acute erythroid leukemia (also known as Guglielmo's disease, and acute Di Guglielmo syndrome) is a rare form of acute myeloid leukemia.
Heilmeyer-Schöner disease
Acute megakaryoblastic leukemia D007947
Acute megakaryoblastic leukemia (AMKL) is a form of acute myeloid leukemia where megakaryoblasts account for approximately 30% of the nucleated cells within the bonemarrow.[78]
Acute panmyelosis with myelofibrosisC94.4(http://apps.who.int/classifications/apps/icd/icd10online/?gc81.htm+c944)
Acute panmyelosis with myelofibrosis (APMF) is a poorly-defined disorder that arises as either a clonal disorder, or following toxic exposure to the bone marrow.
Lymphosarcoma cell leukemia
Acute leukaemia of unspecified cell type
Blastic phase chronic myelogenous leukemia
Blastic phase chronic myelogenous leukemia is a phase of chronic myelogenous leukemia in which more than 30% of the cells in the blood or bone marrow are blast cells.
Acute myeloid leukemia (AML), also known as acute myelogenous leukemia, is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal whiteblood cells that accumulate in the bone marrow and interfere with the production of normal blood cells.[79]
Acute promyelocytic leukemia
Acute basophilic leukemia
Acute eosinophilic leukemia
Acute lymphoblastic leukemia
Acute monocytic leukemia
Acute myeloblastic leukemia with maturation
Acute myeloid dendritic cell leukemia
Adult T-cell leukemia/lymphoma
Aggressive NK-cell leukemia
B-cell prolymphocytic leukemia
B-cell chronic lymphocytic leukemia
B-cell leukemia
Chronic myelogenous leukemia
Chronic myelomonocytic leukemia
Chronic neutrophilic leukemia
Hairy cell leukemia
Myeloma
Condition name ICD-10 coding numberDiseasesDatabase
coding number
MedicalSubject
Headings
Multiple myeloma
Kahler's disease
Myelomatosis
solitary myeloma
Plasma cell leukaemia
Plasmacytoma, extramedullary
Malignant plasma cell tumour NOS
Plasmacytoma NOS
Solitary myeloma
Malignant immunoproliferative diseases
Di M di l
Condition name ICD-10 coding numberDiseasesDatabase
Idiopathic thrombocytopenic purpura (ITP) is the condition of having a low platelet count (thrombocytopenia) of no known cause (idiopathic).
Recurrent thrombosis
Hemophilia
Hemophilia A
Hemophilia B
Hemophilia C
Von Willebrand disease
Antiphospholipid syndrome
Thrombocytopenia
Glanzmann's thrombasthenia
Wiskott Aldrich syndrome
Infection-related
Hematological disorders may be caused by a number of infection-related conditions involving the introduction of microorganisms into the host, such as bacteria and protozoa.[38]
Bacterium-related
Condition name ICD-10 coding numberDiseasesDatabase
coding number
MedicalSubject
Headings
Clostridium infection
Cholera infection
E. coli 0157:H7 infection
Typhoid fever
Protozoan-related
Condition name ICD-10 coding numberDiseasesDatabase
coding number
MedicalSubject
Headings
Leishmania infection *
Malaria infection (Plasmodium infection)
toxoplasmosis
Immune system regulation-related
Immunodeficiency with predominantly antibody defects
Condition name ICD-10 coding numberDiseasesDatabase
coding number
MedicalSubject
Headings
Hereditary hypogammaglobulinemia
Nonfamilial hypogammaglobulinemia
Selective deficiency of immunoglobulin A [IgA]
Selective deficiency of immunoglobulin G [IgG] subclasses
Selective deficiency of immunoglobulin M [IgM]
Immunodeficiency with increased immunoglobulin M [IgM]
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
Transient hypogammaglobulinemia of infancy
References
1. ^ Saladin, Kenneth S.; Miller, Leslie (2004). "18". Anatomy & Physiology: The Unity of form and Function (3rd ed.). Mc Graw-Hill. pp. 679. ISBN 0-07-242903-8.
2. ^ a b MedicineNet.com --> Definition of Anemia (http://www.medterms.com/script/main/art.asp?articlekey=15491) Last Editorial Review: 12/9/2000 Retrieved March 27, 20113. ^ merriam-webster dictionary --> anemia (http://www.merriam-webster.com/dictionary/anemia) Retrieved on March 27, 20114. ^ "Anemia or Iron Deficiency" (http://www.cdc.gov/nchs/fastats/anemia.htm) . Centers for Disease Control and Prevention. Last reviewed April 15, 2010.
http://www.cdc.gov/nchs/fastats/anemia.htm. Retrieved 28 March 2011.5. ^ Brady PG (2007). "Iron deficiency anemia: a call for" (http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?
7. ^ Mayo Clinic staff (March 4, 2011). "Vitamin deficiency anemia" (http://www.mayoclinic.com/health/vitamin-deficiency-anemia/DS00325) . Mayo Foundation for Medical Education
y ( ) y ( p y y ) y fand Research. Mayo Clinic. http://www.mayoclinic.com/health/vitamin-deficiency-anemia/DS00325. Retrieved 5 March 2011.
8. ^ "Pernicious anemia" (http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001595/) . National Center for Biotechnology Information (NCBI). U.S. National Library of Medicine.November 23, 2008. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001595/. Retrieved 1 March 2011.
9. ^ Gräsbeck, R. (May 19, 2006). Imerslund-Gräsbeck syndrome (selective vitamin B(12) malabsorption with proteinuria). National Center for Biotechnology Information, U.S. NationalLibrary of Medicine. PMID 16722557 (http://www.ncbi.nlm.nih.gov/pubmed/16722557) .
10. ^ a b c "Megaloblastic Anemia: Overview - eMedicine Hematology" (http://emedicine.medscape.com/article/204066-overview) . http://emedicine.medscape.com/article/204066-overview. Retrieved 2009-02-07.
11. ^ Kaikov, Y.; L. D. Wadsworth, C. A. Hall and P. C. J. Rogers (1991). "Transcobalamin II deficiency: Case report and review of the literature"(http://www.springerlink.com/content/u31t710158288166/) . European Journal of Pediatrics. European Journal of Pediatrics. pp. Volume 150, Number 12, 841–843, DOI:10.1007/BF01955004. http://www.springerlink.com/content/u31t710158288166/. Retrieved 2 March 2011.
12. ^ Hall, C. A. (November, 1975). Transcobalamins I and II as natural transport proteins of vitamin B12. (http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=301974) . The Journal of Clinical Investigation. pp. 56(5): 1125–1131. doi: 10.1172/JCI108187. PMC 301974(http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=301974) . http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=301974.
13. ^ "Folate-deficiency anemia" (http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001578/) . National Center for Biotechnology Information. U.S. National Library of Medicine.reviewed January 31, 2010. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001578/. Retrieved 2 March 2011.
14. ^ Shahidi, Nasrollah T.; Diamond, Louis K; Shwachman, Harry (October 1961). "Anemia associated with protein deficiency" (http://www.jpeds.com/article/S0022-3476%2861%2980237-0/abstract) . The Journal of Peditrics. Elsevier Inc. http://www.jpeds.com/article/S0022-3476%2861%2980237-0/abstract. Retrieved 28 March 2011.
15. ^ Vorvick, MD, Linda (Updated March 14, 2009). "Scurvy" (http://www.nlm.nih.gov/medlineplus/ency/article/000355.htm) . Medline Plus. U.S. National Library of Medicine.http://www.nlm.nih.gov/medlineplus/ency/article/000355.htm. Retrieved 1 March 2011.
16. ^ Chambers, Diana; Zieve, David Zieve (Last reviewed August 11, 2009). "Bassen-Kornzweig syndrome" (http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002631/) . Pub MedHealth. National Center for Biotechnology Information, U.S. National Library of Medicine. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002631/. Retrieved 23 March 2011.
17. ^ Turgeon, Mary (2005). "8". Clinical Hematology: Theory and Procedures (4th ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 117. ISBN 0-7817-5007-5.18. ^ Online 'Mendelian Inheritance in Man' (OMIM) 141800 (http://omim.org/entry/141800)19. ^ Online 'Mendelian Inheritance in Man' (OMIM) 141850 (http://omim.org/entry/141850)20. ^ "Alpha thalassemia" (http://ghr.nlm.nih.gov/condition/alpha-thalassemia) . Genetics Home Reference. U.S. National Library of Medicine. February 27, 2011.
http://ghr.nlm.nih.gov/condition/alpha-thalassemia. Retrieved 3 March 2011.21. ^ "Anemia of Chronic Disease" (http://www.irondisorders.org/anemia-of-chronic-disease) . Iron Disorders Institute. 2009. http://www.irondisorders.org/anemia-of-chronic-disease.
Retrieved 3 March 2011.22. ^ "Anemia in Kidney Disease and Dialysis" (http://kidney.niddk.nih.gov/kudiseases/pubs/anemia/) . The National Kidney and Urologic Diseases Information Clearinghouse. National
Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. October 2008. http://kidney.niddk.nih.gov/kudiseases/pubs/anemia/. Retrieved 28 March 2011.23. ^ Widness JA (November 2008). "Pathophysiology of Anemia During the Neonatal Period, Including Anemia of Prematurity" (http://www.pubmedcentral.nih.gov/articlerender.fcgi?
24. ^ "Anemia of prematurity" (http://www.uptodate.com/patients/content/topic.do?topicKey=~4ppbbmoywE7y17P) . http://www.uptodate.com/patients/content/topic.do?topicKey=~4ppbbmoywE7y17P. Retrieved 2010-05-31.
25. ^ Aplastic anemia (http://www.mountsinai.org/Patient%20Care/Service%20Areas/Cancer/Diseases%20and%20Conditions?citype=Disease&ciid=Aplastic%20anemia) at Mount SinaiHospital
26. ^ [1] (http://www.mountsinai.org/patient-care/health-library/diseases-and-conditions/autoimmune-hemolytic-anemia) at Mount Sinai Hospital27. ^ "Hemolytic Anemia: Overview - eMedicine Hematology" (http://emedicine.medscape.com/article/201066-overview) . http://emedicine.medscape.com/article/201066-overview.
Retrieved 2009-02-07.28. ^ "Beta thalassemia" (http://ghr.nlm.nih.gov/condition/beta-thalassemia) . Genetics Home Reference. U.S. National Library of Medicine, NIH. March 13, 2011.
http://www.orpha.net/data/patho/Pro/en/BlackfanDiamond-FRenPro429.pdf. Retrieved 1 January 2010.30. ^ Cmejla R, Cmejlova J, Handrkova H, et al. (February 2009). "Identification of mutations in the ribosomal protein L5 (RPL5) and ribosomal protein L11 (RPL11) genes in Czech
31. ^ "Congenital dyserythropoietic anemia" (http://ghr.nlm.nih.gov/condition/congenital-dyserythropoietic-anemia) . Genetics Home Reference. U.S. National Library of Medicine, NationalInstitutes of Health. Reviewed July 2009. http://ghr.nlm.nih.gov/condition/congenital-dyserythropoietic-anemia. Retrieved 22 March 2011.
32. ^ Dhaliwal, Gurpreet; Cornett, Patricia, Tierney, Lawrence (2004). "Hemolytic Anemia" (http://www.aafp.org/afp/2004/0601/p2599.html) . American Family Physician. 2004 Jun1;69(11):2599-2607. American Family of Family Physicians. http://www.aafp.org/afp/2004/0601/p2599.html. Retrieved 28 March 2011.
33. ^ "hemoglobinopathy (http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/four/000048231.htm) " at Dorland's MedicalDictionary
34. ^ Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704-712.35. ^ Hemoglobinopathies and Thalassemias (http://web2.airmail.net/uthman/hemoglobinopathy/hemoglobinopathy.html)36. ^ "Sickle Cell Trait and Other Hemoglobinopathies and Diabetes: Important Information for Physicians" (http://diabetes.niddk.nih.gov/dm/pubs/hemovari-A1C/index.htm) . National
Diabetes Information Clearinghouse. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. November 2008.http://diabetes.niddk.nih.gov/dm/pubs/hemovari-A1C/index.htm. Retrieved 3 March 2011.
37. ^ Reviewed by Vorvick, Linda J.; Chen, Yi-Bin (Reviewed January 31, 2010). "Hemolytic anemia" (http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001597/) . Pub Med Health.National Center for Biotechnology Information, U.S. National Library of Medicine. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001597/. Retrieved 24 March 2011.
38. ^ a b Turgeon, Mary Louise (2004). "12". Clinical Hematology (4th ed.). Lippincott Williams & Wilkins. p. 161. ISBN 0-7817-5007-5.39. ^ Cotran, Ramzi S.; Kumar, Vinay; Fausto, Nelson; Nelso Fausto; Robbins, Stanley L.; Abbas, Abul K. (2005). Robbins and Cotran pathologic basis of disease. St. Louis, Mo: Elsevier
Saunders. pp. 625. ISBN 0-7216-0187-1.40. ^ Tavares, Simone; Sills, Richard (Last updated January 3, 2011). "Pediatric Hereditary Elliptocytosis and Related Disorders" (http://emedicine.medscape.com/article/955827-overview)
. eMedicine. http://emedicine.medscape.com/article/955827-overview. Retrieved 28 March 2011.41. ^ Yawata, Yoshihito (2003). Cell membrane: the red blood cell as a model (http://books.google.com/books?
id=_HFyKIAN2p8C&pg=PA227&lpg=PA227&dq=Hereditary+pyropoikilocytosis&source=vrt&ots=115KXLCnCa&sig=Xgdw21VBHTRInD8CwkTkzWaTdl4&hl=en&ei=gmeiTaejH8OftwepuayQAw&sa=X&oi=book_result&ct=result&resnum=11&ved=0CGMQ6AEwCg#v=onepage&q=Hereditary%20pyropoikilocytosis&f=false) . Wiley-VCH. p. 227.http://books.google.com/books?id=_HFyKIAN2p8C&pg=PA227&lpg=PA227&dq=Hereditary+pyropoikilocytosis&source=vrt&ots=115KXLCnCa&sig=Xgdw21VBHTRInD8CwkTkzWaTdl4&hl=en&ei=gmeiTaejH8OftwepuayQAw&sa=X&oi=book_result&ct=result&resnum=11&ved=0CGMQ6AEwCg#v=onepage&q=Hereditary%20pyropoikilocytosis&f=false. Retrieved 11 April 2011.
43. ^ "Paroxysmal cold hemoglobinuria (PCH) e" (http://www.nlm.nih.gov/medlineplus/ency/article/000557.htm) . Medline Plus. U.S. Department of Health and Human Services, NationalInstitutes of Health. Last updated March 28, 2010. http://www.nlm.nih.gov/medlineplus/ency/article/000557.htm. Retrieved 28 March 2011.
44. ^ "Hemolytic Uremic Syndrome in Children" (http://kidney.niddk.nih.gov/kudiseases/pubs/childkidneydiseases/hemolytic_uremic_syndrome/) . National Kidney and Urologic DiseasesInformation Clearinghouse. National Institutes of Health of the U.S. Department of Health and Human Services. January 2009.http://kidney.niddk.nih.gov/kudiseases/pubs/childkidneydiseases/hemolytic_uremic_syndrome/. Retrieved 4 March 2011.
45. ^ Rijksen, G; Staal, G E. (August 1978). "Human erythrocyte hexokinase deficiency. Characterization of a mutant enzyme with abnormal regulatory properties."(http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=371766) . The Journal of Clinical Investigation (National Center for Biotechnology Information, U.S.National Library of Medicine) PMC 371766 (http://www pubmedcentral gov/articlerender fcgi?tool=pmcentrez&artid=371766) http://www pubmedcentral nih gov/articlerender fcgi?
National Library of Medicine). PMC 371766 (http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=371766) . http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=371766.
46. ^ Wilson, William C.; Grande, Christopher M., Hoyt, David B. (2007). "Trauma: Critical Care" (http://books.google.com/books?id=3H3AIEtvc8YC&pg=PA962&lpg=PA962&dq=Hypochromic+anemia+pale+cells&source=bl&ots=p4J4yC2eRe&sig=mhgZnqQ65fbr25e7y2bbt0JD98A&hl=en&ei=T0GVTabbJom90QGotanxCw&sa=X&oi=book_result&ct=result&resnum=7&ved=0CEAQ6AEwBg#v=onepage&q=Hypochromic%20anemia%20pale%20cells&f=false) . Google books. CRC press.p. 962. http://books.google.com/books?id=3H3AIEtvc8YC&pg=PA962&lpg=PA962&dq=Hypochromic+anemia+pale+cells&source=bl&ots=p4J4yC2eRe&sig=mhgZnqQ65fbr25e7y2bbt0JD98A&hl=en&ei=T0GVTabbJom90QGotanxCw&sa=X&oi=book_result&ct=result&resnum=7&ved=0CEAQ6AEwBg#v=onepage&q=Hypochromic%20anemia%20pale%20cells&f=false. Retrieved 1 April 2011.
47. ^ Rivella, S. (May 2009). Ineffective erythropoiesis and thalassemias. National Center for Biotechnology Information, U.S. National Library of Medicine. PMID 19318943(http://www.ncbi.nlm.nih.gov/pubmed/19318943) .
48. ^ "Ineffective Erythropoiesis" (http://www.nejm.org/doi/full/10.1056/NEJM196209132671113) . The New England Journal of Medicine. September 13, 1962.http://www.nejm.org/doi/full/10.1056/NEJM196209132671113. Retrieved 22 March 2011.
49. ^ "Hematopathology" (http://library.med.utah.edu/WebPath/HEMEHTML/HEME030.html) . http://library.med.utah.edu/WebPath/HEMEHTML/HEME030.html.50. ^ "NINDS Neuroacanthocytosis Information Page" (http://www.ninds.nih.gov/disorders/neuroacanthocytosis/neuroacanthocytosis.htm) . National Institute of Neurological Disorders
and Stroke. National Institutes of Health. Last updated March 16, 2009. http://www.ninds.nih.gov/disorders/neuroacanthocytosis/neuroacanthocytosis.htm. Retrieved 11 April 2011.51. ^ "CHOREOACANTHOCYTOSIS; CHAC" (http://www.omim.org/entry/200150?search=Chorea%20acanthocytosis) . Online Mendelian Inheritance in Man. Johns Hopkins
University. http://www.omim.org/entry/200150?search=Chorea%20acanthocytosis. Retrieved 11 April 2011.52. ^ "Chorea-acanthocytosis" (http://ghr.nlm.nih.gov/condition/chorea-acanthocytosis) . Genetic Home Refrense. U.S. National Library of Medicine, National Institutes of Health. May
2008. http://ghr.nlm.nih.gov/condition/chorea-acanthocytosis. Retrieved 11 April 2011.53. ^ Online 'Mendelian Inheritance in Man' (OMIM) 266200 (http://omim.org/entry/266200)54. ^ Cherif-Zahar, B.; Raynal, V., Le Van Kim, C, D'Ambrosio, AM, Bailly, P., Cartron, JP and Colin, Y. (April 6, 2011). "Structure and expression of the RH locus in the Rh-deficiency
56. ^ Sideroblastic Anemias: Anemias Caused by Deficient Erythropoiesis (http://www.merck.com/mmpe/sec11/ch130/ch130c.html) at Merck Manual of Diagnosis and TherapyProfessional Edition
57. ^ "Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3 -- Allen et al. 60 (6): 1056 -- American Journal of Tropical Medicine andHygiene" (http://www.ajtmh.org/cgi/reprint/60/6/1056) . http://www.ajtmh.org/cgi/reprint/60/6/1056. Retrieved 2008-02-26.
58. ^ "Spur-cell hemolytic anemia in severe alcoholic cirrhosis" (http://bloodjournal.hematologylibrary.org/content/101/1/3.full) . Journal of the American Society of Hematology. TheAmerican Society of Hematology. January 1, 2003. http://bloodjournal.hematologylibrary.org/content/101/1/3.full. Retrieved 10 April 2011.
59. ^ Ralser, Markus; Heeren, Gino; Breitenbach. Michael; Lehrach, Hans; and Krobitsch, Sylvia (December 20, 2006). "Triose Phosphate Isomerase Deficiency Is Caused by AlteredDimerization–Not Catalytic Inactivity–of the Mutant Enzymes" (http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1762313) . PLoS ONE (National Centerfor Biotechnology Information, U.S. National Library of Medicine). PMC 1762313 (http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=1762313) .http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1762313.
60. ^ "Autoimmune Hemolytic Anemia" (http://www.merckmanuals.com/home/sec14/ch172/ch172f.html) . The Merck Manuals: Online Medical Library. Merck Sharp and Dohme.http://www.merckmanuals.com/home/sec14/ch172/ch172f.html. Retrieved 25 March 2011.
61. ^ "Hematologic (Blood) Cancers" (http://www.cdc.gov/cancer/hematologic/) . Centers for Disease Control and Prevention. http://www.cdc.gov/cancer/hematologic/. Retrieved 25January 2011.
62. ^ McPhee, Stephen; Ganong, William (2003). "Chapter 5: Neoplasia". Pathophysiology of Disease (5th ed.). New York: Lange Medical Books/McGraw-Hill. pp. 106 â 110. ISBN 0-07-144159-X.
63. ^ "Blood Cancers: Leukemia, Lymphoma, and Myeloma" (http://www.cdc.gov/Features/HematologicCancers/) . Centers for Disease Control and Prevention.http://www.cdc.gov/Features/HematologicCancers/. Retrieved 5 April 2011.
64. ^ "non-Hodgkin lymphomas (http://www.mercksource.com/pp/us/cns/cns_hl_dorlands_split.jsp?pg=/ppdocs/us/common/dorlands/dorland/nine/000954456.htm) " at Dorland'sMedical Dictionary
65. ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
66. ^ a b [2] (http://www.iarc.fr/WHO-BlueBooks/BBwebsite/bb3.html) Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumors.Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon 2001
67. ^ Elaine Sarkin Jaffe, Nancy Lee Harris, World Health Organization, International Agency for Research on Cancer, Harald Stein, J.W. Vardiman (2001). Pathology and genetics oftumours of haematopoietic and lymphoid tissues (http://books.google.com/?id=XSKqcy7TUZUC) . World Health Organization Classification of Tumors. 3. Lyon: IARC Press.ISBN 92-832-2411-6. http://books.google.com/?id=XSKqcy7TUZUC.
68. ^ Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M (February 2007). "Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatorybowel disease" (http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005176-200702000-00019) . J. Pediatr. Gastroenterol. Nutr. 44 (2):265–7. doi:10.1097/MPG.0b013e31802f6424 (http://dx.doi.org/10.1097%2FMPG.0b013e31802f6424) . PMID 17255842 (http://www.ncbi.nlm.nih.gov/pubmed/17255842) .http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005176-200702000-00019.
69. ^ O’Connor,, Owen A.; Vose, Julie M. (March 2008). "Getting The Facts: Indolent Follicular Lymphoma" (http://www.lymphoma.org/atf/cf/%7B0363cdd6-51b5-427b-be48-e6af871acec9%7D/INDOLENT%20FOLLICULAR.PDF) . Lymphoma Research Foundation. http://www.lymphoma.org/atf/cf/%7B0363cdd6-51b5-427b-be48-e6af871acec9%7D/INDOLENT%20FOLLICULAR.PDF. Retrieved 2 April 2011.
70. ^ Storey, Rowland; Gatt, Marcell, Bradford, Ian (January 6, 2009). [; "Mucosa associated lymphoid tissue lymphoma presenting within a solitary anti-mesenteric dilated segment ofileum: a case report"]. Journal of Medical Case Reports. BioMed Central. Archived from the original (http://jmedicalcasereports.com/content/3/1/6) . Error: If you specify|archiveurl=, you must also specify |archivedate=.
. Retrieved 2 April 2011.
71. ^ "Leukemia - Chronic Lymphocytic - CLL" (http://www.cancer.net/patient/Cancer+Types/Leukemia+-+Chronic+Lymphocytic+-+CLL) . Cancer.Net. American Society of ClinicalOncology (ASCO). Last Updated: December 02, 2010. http://www.cancer.net/patient/Cancer+Types/Leukemia+-+Chronic+Lymphocytic+-+CLL. Retrieved 2 April 2011.
72. ^ Turgeon, Mary Louise (2005). Clinical hematology: theory and procedures. Hagerstown, MD: Lippincott Williams & Wilkins. pp. 283. ISBN 0-7817-5007-5.73. ^ "Waldenström Macroglobulinemia" (http://www.mayoclinic.org/waldenstroms-macroglobulinemia/) . Mayo Clinic. Mayo Foundation for Medical Education and Research.
http://www.mayoclinic.org/waldenstroms-macroglobulinemia/. Retrieved 4 April 2011.74. ^ Franco,, Vito; Florena, Ada Maria, Iannitto, Emilio (November 21, 2002). "Splenic marginal zone lymphoma" (http://bloodjournal.hematologylibrary.org/content/101/7/2464.full.html)
. Journal of the American Society of Hematology. American Society of Hematology. http://bloodjournal.hematologylibrary.org/content/101/7/2464.full.html. Retrieved 4 April 2011.75. ^ Jones, Dan; Ballestas, Mary E., Kaye, Kenneth M., Gulizia, James M., Winters, Gayle L., Fletcher, Jonathan, Scadden, David T., and Aster, Jon C. (August 13, 1998). "Primary-
Effusion Lymphoma and Kaposi's Sarcoma in a Cardiac-Transplant Recipient" (http://www.nejm.org/doi/full/10.1056/NEJM199808133390705) . The New England Journal ofMedicine. Massachusetts Medical Society.. http://www.nejm.org/doi/full/10.1056/NEJM199808133390705. Retrieved 4 April 2011.
76. ^ Chan SM, George T, Cherry AM, Medeiros BC (February 2009). "Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a casereport" (http://www.casesjournal.com/content/2/1/121) . Cases J 2 (1): 121. doi:10.1186/1757-1626-2-121 (http://dx.doi.org/10.1186%2F1757-1626-2-121) . PMC 2644294(http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=2644294) . PMID 19192311 (http://www.ncbi.nlm.nih.gov/pubmed/19192311) .http://www.casesjournal.com/content/2/1/121.
77. ^ Kim SJ, Kim J, Cho Y, Seo BK, Kim BS (May 2007). "Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cellleukemia" (http://jjco.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=17538191) . Jpn. J. Clin. Oncol. 37 (5): 382–4. doi:10.1093/jjco/hym037(http://dx doi org/10 1093%2Fjjco%2Fhym037) PMID 17538191 (http://www ncbi nlm nih gov/pubmed/17538191) http://jjco oxfordjournals org/cgi/pmidlookup?
78. ^ Gassmann W,; Löffler H. (1995). Acute megakaryoblastic leukemia. National Center for Biotechnology Information, U.S. National Library of Medicine. pp. Leukemia andLymphoma. 18 Suppl 1:69–73.. PMID 7496359 (http://www.ncbi.nlm.nih.gov/pubmed/7496359) .
79. ^ Lowenberg, M.D., Bob; Downing M.D., James R., Burnett M.D., Alan (September 30, 1999). "Acute myeloid leukemia" (https://www.e-value.net/ndfiles/EvalueMProd_Collections/155/155Article_Library/Heme_Onc_Required_Readings_1.pdf) . The New England Journal of Medicine. Massachusetts Medical Society.pp. page 1051 Volume 341 Number 14. https://www.e-value.net/ndfiles/EvalueMProd_Collections/155/155Article_Library/Heme_Onc_Required_Readings_1.pdf. Retrieved 8 March2011.
80. ^ Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (1981). "Deficiency of protein C in congenital thrombotic disease" (http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=370934) . J. Clin. Invest. 68 (5): 1370–3. doi:10.1172/JCI110385 (http://dx.doi.org/10.1172%2FJCI110385) . PMC 370934(http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=370934) . PMID 6895379 (http://www.ncbi.nlm.nih.gov/pubmed/6895379) .http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=370934. Full text at PMC: 370934 (http://www.ncbi.nlm.nih.gov/pmc/articles/PMC370934/)
Retrieved from "http://en.wikipedia.org/wiki/List_of_hematologic_conditions"Categories: Medical lists | Lists of diseases | Blood disorders
This page was last modified on 12 September 2011 at 03:01.Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. See Terms of use for details.Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
